Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy

Neoplasia : an International Journal for Oncology Research
Toru ShibataJ Martin Brown

Abstract

Previous studies have suggested that tumor hypoxia could be exploited for cancer gene therapy. Using hypoxia-responsive elements derived from the human vascular endothelial growth factor gene, we have generated vectors expressing a bacterial nitroreductase (NTR) gene that can activate the anticancer prodrug CB1954. Stable transfectants of human HT1080 tumor cells with hypoxia-inducible vectors were established with G418 selection. Hypoxic induction of NTR protein correlated with increased sensitivity to in vitro exposure of HT1080 cells to the prodrug. Growth delay assays were performed with established tumor xenografts derived from the same cells to detect the in vivo efficacy of CB1954 conversion to its cytotoxic form. Significant antitumor effects were achieved with intraperitoneal injections of CB1954 both in tumors that express NTR constitutively or with a hypoxia-inducible promoter. In addition, respiration of 10% 02 increased tumor hypoxia in vivo and enhanced the antitumor effects. Taken together, these results demonstrate that hypoxia-inducible vectors may be useful for tumor-selective gene therapy, although the problem of delivery of the vector to the tumors, particularly to the hypoxic cells in the tumors, is not add...Continue Reading

References

Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·B E HuberT A Krenitsky
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M A GoldbergH F Bunn
Feb 1, 1989·Journal of the National Cancer Institute·M C BibbyC V Duke
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A Madan, P T Curtin
Jan 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M HöckelP Vaupel
Dec 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A BridgewaterM K Collins
Jan 17, 1997·The Journal of Biological Chemistry·S ChenL M Amzel
May 1, 1997·Nature Medicine·G U DachsA L Harris
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·P H MaxwellP J Ratcliffe
May 1, 1997·International Journal of Radiation Oncology, Biology, Physics·D M BrizelM W Dewhirst
Sep 25, 1998·International Journal of Radiation Oncology, Biology, Physics·A BeckerJ Dunst
Jan 14, 1999·Urology·B MovsasG E Hanks
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·M F AdamJ M Brown
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·H RuanD F Deen

❮ Previous
Next ❯

Citations

Sep 29, 2011·Journal of Radiation Research·Hiroshi Harada
Nov 24, 2018·Current Drug Targets·Min-Xia SuJin-Jian Lu
Jun 2, 2004·Nature Reviews. Cancer·J Martin Brown, William R Wilson
Nov 11, 2006·Cancer Gene Therapy·M Bazan-PeregrinoA L Harris
Sep 11, 2012·International Journal of Molecular Medicine·Junfeng ZhangYong Liu
Oct 21, 2003·Journal of Cellular Physiology·Olga GrecoSimon D Scott
Dec 5, 2006·Biological & Pharmaceutical Bulletin·Hideko NagasawaHitoshi Hori
Mar 9, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Gisele HöpflMax Gassmann
Mar 21, 2003·Gene Therapy·K BinleyS Naylor
Jul 25, 2006·Expert Opinion on Investigational Drugs·Pamela J Russell, Aparajita Khatri
Nov 9, 2016·Cancer Investigation·Hamed Manoochehri KhoshinaniRezvan Najafi
Oct 10, 2008·The British Journal of Radiology·R L CowenK J Williams
Oct 9, 2012·Cancer Research·Hanna M LeinonenAnna-Liisa Levonen
Jan 5, 2002·Neoplasia : an International Journal for Oncology Research·D VordermarkJ M Brown
Sep 12, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Minhyung LeeSung Wan Kim
Oct 19, 2006·Pharmacology & Therapeutics·KangAe LeeJohn J LaPres

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.